drugset / Trial / NCT02903524
Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluate the efficacy and safety of Doxorubicin Hydrochloride Liposome Injection Plus Cyclophosphamide Compared to Pirarubicin Plus Cyclophosphamide as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
Timeline
- Start
- 2016-09
- Primary completion
- 2018-09
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | — | — |
| Comparator | Pirarubicin | Small molecule | — | — |
| Comparator | Cyclophosphamide | Other / unclassified | — | — |